Research Reports

Strong order book masks margin compression amid transformation

organizational restructuring · margin recovery · pharma revival

Revenue +22%, PAT -96% — margin collapse swallows growth

margin pressure · raw material volatility · price hikes

AI narrative masks flat profit growth and margin squeeze

mega deal ramp-up · AI native platform · margin compression

Margin beat masked by net loss; execution sound, scale pending

EBITDA expansion · ADC platform · overseas utilization

Canara HSBC Life Insurance Company Ltd: QQ1 Earnings Call

Strong growth, asset quality wobble amid seasonal headwinds

growth momentum · asset quality pressure · branch expansion

Record PAT growth offset by flagged Q3 margin squeeze

margin pressure · raw material costs · pricing action

Strong Q1 profit but margin guidance conservative; H2 project delivery key

PAT +83% · margin discipline · project orders H2

Beat FY27 guidance, large CDMO deal; capacity constraints cap near-term

CDMO momentum · contract wins · capacity expansion

Strong Q1 growth, margin compressed by geopolitical costs

respiratory launches · oncology ramp · cost pressures

Margin beat, volume growth nascent, capex-heavy pivot underway

margin expansion · volume recovery · Morbi disruption gain

Earnings growth masks revenue stall; margin pressure ahead under bank competition

margin compression · portfolio growth lag · asset quality improving

Presales +15.9%, but profit sank 12.9%; margin squeeze and RERA delays cloud H2 outlook

approval delays · margin compression · presales growth

Record earnings, margin durability in question amid capex ramp

record profitability · margin expansion · capacity ramp

Capex ramped, earnings stumbled; transmission delays push renewables to FY28

renewable delays · LNG headwind · Nabha accretion

Zoetis loss cripples Q1; new strategy unproven but credible

Librela destocking · CDMO pivot · customer concentration

Operational turnaround masks ₹3,754 Cr loss; capex delays threaten guidance

net subscriber additions · ARPU expansion · capex delays

NCR breakthrough masks Q1 margin compression and revenue miss

Three Sixty North · NCR expansion · ₹8000 Cr bookings

Record throughput, historic loss: inventory crisis masks structural upside

inventory write-down · marketing under-recovery · HRRL ramp-up

Volume beat by pricing; PAT misses growth narrative

pricing power · volume headwinds · margin normalization

Strong volume, margin gap: PAT down 16.9% despite +35% revenue

volume growth · EV momentum · commodity headwinds

Strong growth masked by margin pressure; semaglutide setback derails targets

JB integration · cost synergies · semaglutide supply

Record Q1 profit on 75% PAT growth; pharma & gas capex on track

PAT growth · capex · specialty chemicals

Strong quarter, temporary tailwinds—guidance held firm

trading arbitrage · basis normalization · price volatility

Base business solid, semaglutide stumble masks underlying strength

semaglutide recovery · abatacept pathway · emerging markets growth

36% revenue collapse, PAT salvaged by forex; structural headwinds persist

commodity-driven decline · forex windfall · aluminum pressure

Strong refining growth masked by LPG losses and margin compression

refinery expansion · geopolitical risk · LPG under-recovery

Strong PAT but margin pressure; costs outpace price recovery

margin compression · cost headwinds · import surge

Strong PAT growth masks cautious posture; advance lag and slippage rise

responsible growth · calibrated risk · margin stability

Strong volume growth corroborated; long-term capex positioned, margins guarded

volume-led growth · capacity expansion · specialty ingredients